NASDAQ:OLMA | Insider Transactions | Olema Pharmaceuticals, Inc.

OLMA Insider Transactions

271 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

OLMA insiders transaction timeline

PurchaseSale
2020-11-19: 30 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2020-11-23: 6 purchases — Cormorant Asset Management, LP, Chen Bihua, Cormorant Global Healthcare Master Fund, LP and 3 more2021-05-18: 2 sales — Horn Kinney2021-06-10: 3 sales — Horn Kinney2021-06-18: 3 sales — Harmon Cyrus2021-07-12: 2 sales — Horn Kinney2021-07-19: 1 sale — Harmon Cyrus2021-07-20: 1 sale — Harmon Cyrus2021-08-10: 2 sales — Horn Kinney2021-08-19: 1 sale — Harmon Cyrus2021-09-01: 1 sale — Bohen Sean2021-09-07: 1 sale — Bohen Sean2021-09-08: 1 sale — Bohen Sean2021-09-10: 1 sale — Horn Kinney2021-09-20: 1 sale — Harmon Cyrus2021-09-27: 1 sale — Bohen Sean2021-10-11: 2 sales — Horn Kinney2021-10-14: 2 sales — Bohen Sean2021-10-19: 2 sales — Harmon Cyrus2021-11-10: 1 sale — Horn Kinney2021-11-29: 1 sale — Harmon Cyrus2021-11-30: 30 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2021-12-10: 2 sales — Horn Kinney, Myles David C.2022-01-10: 1 sale — Horn Kinney2022-03-10: 1 sale — Horn Kinney2022-06-10: 20 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2022-09-02: 1 purchase — Kovacs Shane William Charles2022-09-21: 1 purchase — Bohen Sean2023-04-06: 1 purchase — Kovacs Shane William Charles2023-06-05: 1 sale — Harmon Cyrus2023-06-06: 1 sale — Harmon Cyrus2023-06-08: 1 sale — Harmon Cyrus2023-08-16: 2 sales — Harmon Cyrus2023-08-31: 1 sale — Harmon Cyrus2023-09-05: 1 sale — Harmon Cyrus2023-09-12: 31 purchases — Graham G. Walmsley, BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL and 8 more2023-09-19: 1 sale — Myles David C.2023-09-29: 1 sale — Harmon Cyrus2023-10-31: 1 sale — Harmon Cyrus2023-11-01: 1 sale — Myles David C.2023-11-02: 2 sales — Myles David C., Harmon Cyrus2023-11-03: 1 sale — Myles David C.2023-11-08: 1 sale — Myles David C.2023-11-21: 9 sales — Zojwalla Naseem, Myles David C., Harmon Cyrus and 2 more2023-11-22: 5 sales — Zojwalla Naseem, Myles David C., Harmon Cyrus and 2 more2023-11-30: 1 sale — Harmon Cyrus2023-12-05: 3 purchases — Graham G. Walmsley2023-12-06: 4 purchases — Paradigm BioCapital International Fund Ltd., Paradigm Biocapital Advisors LP, Paradigm BioCapital Advisors GP LLC and 1 more2023-12-29: 2 sales — Harmon Cyrus2024-01-31: 1 sale — Harmon Cyrus2024-02-01: 1 sale — Harmon Cyrus2024-02-29: 2 sales — Harmon Cyrus2024-03-28: 1 sale — Harmon Cyrus2024-04-30: 1 sale — Harmon Cyrus2024-05-06: 1 sale — Harmon Cyrus2024-05-31: 1 sale — Harmon Cyrus2024-06-03: 1 sale — Harmon Cyrus2024-06-04: 5 sales — Graham G. Walmsley, Harmon Cyrus2024-06-28: 1 sale — Harmon Cyrus2024-07-11: 1 sale — Harmon Cyrus2024-07-29: 1 sale — Harmon Cyrus2024-07-30: 1 sale — Harmon Cyrus2024-08-01: 8 sales — Paradigm BioCapital International Fund Ltd., Paradigm Biocapital Advisors LP, Paradigm BioCapital Advisors GP LLC and 1 more2024-12-10: 5 sales — Harmon Cyrus, Myles David C., Zojwalla Naseem and 2 more2024-12-11: 10 sales — Harmon Cyrus, Myles David C., Zojwalla Naseem and 2 more2024-12-13: 1 purchase — Graham G. Walmsley2024-12-13: 1 sale — Graham G. Walmsley2024-12-17: 1 purchase — Graham G. Walmsley2024-12-17: 1 sale — Graham G. Walmsley2025-01-08: 5 purchases — Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences IV General Partner, LLC, Bain Capital Life Sciences Fund IV, L.P. and 2 more2025-09-16: 2 sales — Harmon Cyrus2025-09-18: 2 sales — Harmon Cyrus2025-12-19: 8 sales — Zojwalla Naseem, Myles David C., CLARK IAN T2025-12-22: 2 sales — Harmon Cyrus, Zojwalla Naseem2025-12-23: 1 sale — Zojwalla Naseem2026-01-12: 1 sale — Myles David C.2026-01-13: 3 sales — Kovacs Shane William Charles, Myles David C.2026-01-14: 3 sales — Harmon Cyrus, Myles David C.2026-01-15: 1 sale — Kovacs Shane William Charles2026-01-20: 1 sale — Harmon Cyrus2026-03-03: 1 sale — Mitchell Shawnte2026-03-04: 2 sales — Mitchell Shawnte2026-07-23: 1 sale — Harmon Cyrus2026-07-24: 1 sale — Harmon Cyrus2020-11-192026-07-24
Insider profileRoleDateTransactionSharesPrice
Harmon CyrusDirector2026-07-24Sale12,500$11.714
Harmon CyrusDirector2026-07-23Sale12,500$11.579
Mitchell ShawnteCHIEF LEGAL OFFICER2026-03-04Sale233.0$24.69
Mitchell ShawnteCHIEF LEGAL OFFICER2026-03-04Sale24,767.0$24.25
Mitchell ShawnteCHIEF LEGAL OFFICER2026-03-03Sale15,000.0$23.01
Harmon CyrusDirector2026-01-20Sale10,000.0$26.88
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2026-01-15Sale100,000.0$28.73
Harmon CyrusDirector2026-01-14Sale3,489.0$29.12
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2026-01-14Sale35,003.0$28.99
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2026-01-14Sale14,997.0$28.6
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2026-01-13Sale3,822.0$28.01
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2026-01-13Sale200.0$28.49
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2026-01-13Sale49,800.0$27.6
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2026-01-12Sale10,000.0$28.34
Zojwalla NaseemChief Medical Officer2025-12-23Sale99,509.0$27.66
Harmon CyrusDirector2025-12-22Sale2,881.0$28.53
Zojwalla NaseemChief Medical Officer2025-12-22Sale100,000.0$28.04
Zojwalla NaseemChief Medical Officer2025-12-19Sale12,921.0$28.93
Zojwalla NaseemChief Medical Officer2025-12-19Sale57,079.0$28.03
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2025-12-19Sale6,046.0$31.39
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2025-12-19Sale43,729.0$30.4
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2025-12-19Sale1,225.0$28.08
CLARK IAN TDirector2025-12-19Sale41,840.0$30.48
CLARK IAN TDirector2025-12-19Sale193,056.0$29.71
CLARK IAN TDirector2025-12-19Sale29,904.0$28.83
Harmon CyrusDirector2025-09-18Sale3,086.0$8.32
Harmon CyrusDirector2025-09-18Sale10,000.0$8.33
Harmon CyrusDirector2025-09-16Sale1,914.0$8.08
Harmon CyrusDirector2025-09-16Sale10,000.0$8.04
Bain Capital Life Sciences Investors, LLCTenPercentOwner2025-01-08Purchase300,000.0$5.76
Bain Capital Life Sciences IV General Partner, LLCTenPercentOwner2025-01-08Purchase300,000.0$5.76
Bain Capital Life Sciences Fund IV, L.P.TenPercentOwner2025-01-08Purchase300,000.0$5.76
Bain Capital Life Sciences Opportunities IV, L.P.TenPercentOwner2025-01-08Purchase300,000.0$5.76
Bain Capital Life Sciences Opportunities IV GP, LLCTenPercentOwner2025-01-08Purchase300,000.0$5.76
Graham G. WalmsleyDirector2024-12-17Purchase700,761.0$6.75
Graham G. WalmsleyDirector2024-12-17Sale700,761.0$6.75
Graham G. WalmsleyDirector2024-12-13Purchase700,761.0$6.75
Graham G. WalmsleyDirector2024-12-13Sale700,761.0$6.75
Harmon CyrusDirector2024-12-11Sale179.0$9.39
Harmon CyrusDirector2024-12-11Sale7,958.0$8.66
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2024-12-11Sale300.0$9.39
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2024-12-11Sale13,314.0$8.66
Zojwalla NaseemCHIEF MEDICAL OFFICER2024-12-11Sale320.0$9.39
Zojwalla NaseemCHIEF MEDICAL OFFICER2024-12-11Sale14,202.0$8.66
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2024-12-11Sale406.0$9.39
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2024-12-11Sale17,950.0$8.66
Bohen SeanPRESIDENT AND CEO2024-12-11Sale1,267.0$9.39
Bohen SeanPRESIDENT AND CEO2024-12-11Sale55,907.0$8.66
Harmon CyrusDirector2024-12-10Sale8,256.0$9.37
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2024-12-10Sale12,452.0$9.38
Zojwalla NaseemCHIEF MEDICAL OFFICER2024-12-10Sale13,283.0$9.37
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2024-12-10Sale16,803.0$9.37
Bohen SeanPRESIDENT AND CEO2024-12-10Sale52,328.0$9.37
Paradigm BioCapital International Fund Ltd.TenPercentOwner2024-08-01Sale529,501.0$14.92
Paradigm Biocapital Advisors LPTenPercentOwner2024-08-01Sale529,501.0$14.92
Paradigm BioCapital Advisors GP LLCTenPercentOwner2024-08-01Sale529,501.0$14.92
Asefaw SenaiTenPercentOwner2024-08-01Sale529,501.0$14.92
Paradigm BioCapital International Fund Ltd.TenPercentOwner2024-08-01Sale1,870,499.0$14.92
Paradigm Biocapital Advisors LPTenPercentOwner2024-08-01Sale1,870,499.0$14.92
Paradigm BioCapital Advisors GP LLCTenPercentOwner2024-08-01Sale1,870,499.0$14.92
Asefaw SenaiTenPercentOwner2024-08-01Sale1,870,499.0$14.92
Harmon CyrusDirector2024-07-30Sale934.0$15.55
Harmon CyrusDirector2024-07-29Sale4,066.0$15.58
Harmon CyrusDirector2024-07-11Sale5,000.0$12.26
Harmon CyrusDirector2024-06-28Sale20,000.0$10.77
Graham G. WalmsleyDirector2024-06-04Sale475,000.0$14.85
Graham G. WalmsleyDirector2024-06-04Sale700,000.0$14.85
Graham G. WalmsleyDirector2024-06-04Sale475,000.0$14.85
Graham G. WalmsleyDirector2024-06-04Sale700,000.0$14.85
Harmon CyrusDirector2024-06-04Sale5,000.0$12.33
Harmon CyrusDirector2024-06-03Sale5,000.0$10.93
Harmon CyrusDirector2024-05-31Sale15,000.0$9.41
Harmon CyrusDirector2024-05-06Sale5,000.0$10.92
Harmon CyrusDirector2024-04-30Sale15,000.0$9.51
Harmon CyrusDirector2024-03-28Sale20,000.0$10.97
Harmon CyrusDirector2024-02-29Sale100.0$13.0
Harmon CyrusDirector2024-02-29Sale24,900.0$12.41
Harmon CyrusDirector2024-02-01Sale5,000.0$15.56
Harmon CyrusDirector2024-01-31Sale25,000.0$12.23
Harmon CyrusDirector2023-12-29Sale2,500.0$14.1
Harmon CyrusDirector2023-12-29Sale22,500.0$13.3
Paradigm BioCapital International Fund Ltd.TenPercentOwner2023-12-06Purchase100,000.0$11.6
Paradigm Biocapital Advisors LPTenPercentOwner2023-12-06Purchase100,000.0$11.6
Paradigm BioCapital Advisors GP LLCTenPercentOwner2023-12-06Purchase100,000.0$11.6
Asefaw SenaiTenPercentOwner2023-12-06Purchase100,000.0$11.6
Graham G. WalmsleyDirector2023-12-05Purchase50,000.0$13.09
Graham G. WalmsleyDirector2023-12-05Purchase50,000.0$14.95
Graham G. WalmsleyDirector2023-12-05Purchase31,870.0$14.73
Harmon CyrusDirector2023-11-30Sale25,000.0$12.57
Zojwalla NaseemCHIEF MEDICAL OFFICER2023-11-22Sale7,095.0$13.89
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-22Sale6,653.0$13.89
Harmon CyrusDirector2023-11-22Sale3,989.0$13.9
Bohen SeanPRESIDENT AND CEO2023-11-22Sale27,932.0$13.9
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2023-11-22Sale9,145.0$13.89
Zojwalla NaseemCHIEF MEDICAL OFFICER2023-11-21Sale200.0$15.33
Zojwalla NaseemCHIEF MEDICAL OFFICER2023-11-21Sale7,261.0$14.83
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-21Sale200.0$15.32
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-21Sale6,776.0$14.87
Harmon CyrusDirector2023-11-21Sale4,192.0$14.86
Bohen SeanPRESIDENT AND CEO2023-11-21Sale2,602.0$15.29